Cholesterol & Lipid
Sort by:
Canadian Collaborative Research Network
Emerging Risk Markers - Lp(a) and Coronary Calcium
FEATURING
Khurram Nasir
- 29 views
- December 24, 2024
- 1
Cleveland Clinic Heart, Vascular and Thoracic Institute
Who Should Get a CAC? How Often? How to Use the Results to Assess Risk?
FEATURING
Milind Desai
- 1,164 views
- December 18, 2024
- 11
Cleveland Clinic Heart, Vascular and Thoracic Institute
Targeting Lp(a)
FEATURING
Leslie Cho
- 429 views
- December 18, 2024
- 3
MonteHeart Imaging & Clinical Lectures
Beyond Statins: State of the Art Treatment for Severe Lipid Disorders
FEATURING
Eugenia Gianos
- 1,230 views
- December 12, 2024
- 8
MonteHeart Imaging & Clinical Lectures
AI and Tech for CVD Prevention: Hope, Hype, and Dr. ChatGPT
FEATURING
Ashish Sarraju
- 10 views
- December 9, 2024
Norman Lepor
The Role of Inflammation and Its Management in Cardiometabolic Disease
- 803 views
- December 5, 2024
- 10
Top Ten Topics in Clinical Cardiology 2024
Recommendations for Lipid-Lowering Drugs in Patients with Chronic Coronary Syndrome
FEATURING
Deepak Bhatt
- 143 views
- December 3, 2024
- 1
Right Care Initiative
Fight Heart Disease Like Cancer: Shifting the Paradigm and Empowering Patients
FEATURING
Michael Mcconnell
- 10 views
- December 2, 2024
Michigan Medicine
Developments in the Dyslipidemias
FEATURING
Michael Shea
- 233 views
- November 26, 2024
TCT 2024 Insights
TCT 2024 Insights: Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI
FEATURING
Jennifer Rymer
- 8 views
- November 21, 2024
AHA 2024 Insights
AHA 2024 Insights: Phase 2 Trial of Zerlasiran: Multiple Doses of an siRNA Targeting Lipoprotein(a) Over 60 Weeks
FEATURING
Steven Nissen
- 1,142 views
- November 19, 2024
- 8
The American Society for Preventive Cardiology
LP(a) in Primary Prevention is Actionable Today
FEATURING
Vera Bittner
- 671 views
- November 15, 2024
- 1
The American Society for Preventive Cardiology
LP(a) in Primary Prevention is Actionable Today: Con
FEATURING
Roger Blumenthal
- 701 views
- November 15, 2024
- 1
The American Society for Preventive Cardiology
Reducing Residual CVD Risk: Adding Colchicine
FEATURING
Michael Wilkinson
- 132 views
- November 15, 2024
- 1
The American Society for Preventive Cardiology
Prioritizing Very Low LDL/apoB vs. Colchicine - Turn Off the Fuel Supply of Douse the Flame?
FEATURING
Daniel Soffer
- 275 views
- November 15, 2024
- 1
The American Society for Preventive Cardiology
CAC Is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention
FEATURING
Seamus Whelton
- 89 views
- November 15, 2024
- 1
The American Society for Preventive Cardiology
CCTA Is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention
FEATURING
Matthew Budoff
- 92 views
- November 15, 2024
Right Care Initiative
Intravascular Plaque Anatomic Changes with Lipid Lowering Therapy - Why Optimal Medication Management Matters
FEATURING
Matthew Budoff
- 621 views
- November 15, 2024
- 5
Right Care Initiative
Role of Coronary Artery Calcium Scoring in the Era of PREVENT
FEATURING
Alexander Razavi
- 215 views
- November 15, 2024
- 1
Right Care Initiative
2023 AHA/ACC Guideline for the Management of Patients with Chronic Coronary Disease
FEATURING
Fatima Rodriguez,
David Maron
- 122 views
- November 15, 2024
